Highest-materiality recent filing
Quaker Houghton names Mark Douglas Chairman; Michael Barry retires after 18 years
Michael F. Barry retired as Chairman and director on May 13, 2026 after 18 years on Board, 17 as Chairman.
Quaker Houghton Q1 net sales up 8% to $480.5M; non-GAAP EPS $1.63, up 3% Y/Y
Net sales $480.5M (+8% Y/Y); organic volumes up 3% driven by ~4% new business wins.
Quaker Chemical Amends Credit Agreement, Secures $1.6B in New Facilities
Entered into Amendment No. 4 to credit agreement on April 10, 2026, with $550M U.S. term loan, $250M euro term loan, and $800M revolving credit facility.
Quaker Houghton SVP & Chief Global Operations Officer Jeff Fleck Departs Involuntarily
Jeffrey Fleck no longer serves as SVP, Chief Global Operations Officer effective March 9, 2026.
Quaker Houghton reports Q4 net sales $468.5M (+6% Y/Y); FY2025 net loss $2.5M due to impairment
Q4 net income $20.7M ($1.18 diluted EPS); non-GAAP EPS $1.65, up 24% Y/Y.
Quaker Houghton Q3 net sales +7% to $493.8M; adj. EPS $2.08 (+10% YoY); leverage reduced to 2.4x
Q3 net sales $493.8M (+7% YoY) driven by organic volume +3% and acquisitions +5%; price/mix -2%.
Quaker Houghton reports Q2 net loss of $66.6M on $88.8M impairment; adjusted EPS $1.71 vs $2.13
Q2 net sales $483.4M (+4% Y/Y); organic volumes +2% on new business wins of ~5%.
Jeff Kutz resigns as CAO; Steve Dassing appointed Principal Accounting Officer at Quaker Chemical
Jeff Kutz resigned as Chief Accounting Officer effective July 18, 2025; departure voluntary, no disagreement with Company.
Director Ramaswami Seshasayee retires from Quaker Chemical board; size reduced to 11
Ramaswami Seshasayee retired from the Board effective May 14, 2025, after serving since 2019.
Directors elected: Mark A. Douglas, Sanjay Hinduja, William H. Osborne, Fay West (three-year terms).
Net sales $442.9M, down 6% YoY; net income $12.9M ($0.73 diluted) vs $35.2M ($1.95) in Q1 2024.
Quaker Houghton closes two acquisitions: Dipsol ($153M) and Natech ($5.2M)
Completed acquisition of Dipsol Chemicals for 23B JPY (~$153M); multiple ~10.5x trailing EBITDA of ~$15M.
Quaker Houghton acquires Dipsol Chemicals for ~$153M (23B JPY) to expand advanced solutions
Purchase price ~$153M (23B JPY); ~10.5x Dipsol's trailing 12-month adjusted EBITDA of ~$15M.
Quaker Houghton Q4 net sales down 5% to $444M; adj. EPS drops to $1.33
Q4 net sales $444.1M, down 5% YoY; net income $14.2M ($0.81 diluted EPS) vs $20.2M ($1.12) prior year.
Quaker Chemical awards 5,565 RSUs to CFO Tom Coler and 4,255 RSUs to CSO Jeewat Bijlani
Target RSU awards: Tom Coler (CFO) 5,565 RSUs, Jeewat Bijlani (CSO) 4,255 RSUs.
Quaker Chemical finalizes CEO Tometich's severance; 18 months pay, accelerated equity vesting
Tometich departed Nov 18, 2024; agreement signed Dec 5, 2024 includes 18 months bi-weekly severance at current rate plus prorated AIP at 100% individual target.
Quaker Houghton's SVP & Chief HR Officer Melissa Leneis departs Dec 2, 2024
Melissa Leneis no longer serves as SVP & Chief HR Officer as of December 2, 2024.
Quaker Houghton appoints Joseph Berquist as CEO, replacing Andy Tometich
Joseph Berquist appointed CEO and President effective Nov 18, 2024; also elected to Board as Class I director.
Quaker Houghton Q3 net sales down 6% to $462.3M; non-GAAP EPS $1.89 vs $2.05
Net sales $462.3M, down 6% YoY; net income $32.3M ($1.81 diluted EPS) from $33.7M ($1.87).
Quaker Houghton Q2 net sales $463.6M (-6%); EPS $1.94; adj. EPS $2.13; EBITDA up 5%; dividend +6.6%
Net sales $463.6M, down 6% YoY due to index-based pricing (-4%) and slight volume decline (-1%).
Quaker Houghton appoints Nandita Bakhshi and Lucrèce Foufopoulos-De Ridder to board
Board expanded from 10 to 12 directors; both appointed as independent members effective July 31, 2024.
Shareholders approve 2024 Long-Term Performance Incentive Plan, adding 900K shares for equity awards
Restated Plan approved with ~12.8M For, ~3.3M Against; adds 900K shares to share pool (plus remaining 2016 Plan shares).
Quaker Houghton appoints Tom Coler as CFO effective June 10, 2024; Shane Hostetter departs
Shane Hostetter terminated as CFO effective June 7, 2024; will remain in transition role through August 4, 2024.
Quaker Chemical (KWR) Q1 2024 net sales $469.8M (-6% YoY); adj. EBITDA up 6% to $83.3M
GAAP diluted EPS $1.95 vs $1.64 prior year; non-GAAP EPS $2.09 vs $1.89.
the Board appointed Mr. Mark A. Douglas, an independent director who has served on the Board since 2013, to succeed Mr. Barry as Chairman.
Mr. Michael F. Barry, a member of the Board of Directors (the “Board”) of Quaker Chemical Corporation (the “Company”) notified the Company of his retirement from the Board, effective at the conclusion of the Board meeting on May 13, 2026.
On May 14, 2025, Mr. Ramaswami Seshasayee, a member of the Board of Directors (the “Board”) of Quaker Chemical Corporation (“the Company”) notified the Company of his retirement from the Board, effective on such date.
Additionally, effective as of November 18, 2024, Andrew E. Tometich no longer serves as the Company’s Chief Executive Officer and President or as a member of the Board.
On November 14, 2024, the Board of Directors (the “Board”) of Quaker Chemical Corporation (the “Company”), appointed Joseph A. Berquist, age 53, the Company’s Chief Commercial Officer, to serve as Chief Executive Officer and President, effective November 18, 2024.
elected Nandita Bakhshi and Lucrèce Foufopoulos-De Ridder, as additional members.
elected Nandita Bakhshi and Lucrèce Foufopoulos-De Ridder, as additional members.
On May 9, 2024, Quaker Chemical Corporation (the “Company”) announced the termination of the employment of Shane Hostetter, as the Company’s Chief Financial Officer, effective as of June 7, 2024.
On May 6, 2024, the Board of Directors of the Company appointed Tom Coler, age 50, to Executive Vice President and Chief Financial Officer, effective June 10, 2024.
Max materiality 0.80 · Median 0.70 · Most common event leadership